Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
Author:
Larson Richard A.ORCID, Mandrekar Sumithra J., Huebner Lucas J., Sanford Ben L., Laumann Kristina, Geyer Susan, Bloomfield Clara D.ORCID, Thiede Christian, Prior Thomas W., Döhner Konstanze, Marcucci GuidoORCID, Voso Maria TeresaORCID, Klisovic Rebecca B., Galinsky Ilene, Wei Andrew H.ORCID, Sierra Jorge, Sanz Miguel A.ORCID, Brandwein Joseph M., de Witte Theo, Niederwieser DietgerORCID, Appelbaum Frederick R.ORCID, Medeiros Bruno C.ORCID, Tallman Martin S., Krauter Jürgen, Schlenk Richard F.ORCID, Ganser Arnold, Serve Hubert, Ehninger Gerhard, Amadori Sergio, Gathmann Insa, Döhner Hartmut, Stone Richard M.
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute Novartis
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference32 articles.
1. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. 1996;10:1911–8. 2. Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood. 2001;98:1752–9. 3. Nagel G, Weber D, Fromm E, Erhardt S, Lübbert M, Fiedler W, et al. Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO). Ann Hematol. 2017;96:1993–2003. 4. Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002;99:4326–35. 5. Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, et al. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a Cancer and Leukemia Group B study. Cancer Res. 2001;61:7233–9.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|